Yayın: Phase II trial of a combination of weekly docetaxel and four-weekly carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC)
| dc.contributor.author | Özgüroğlu, Mustafa | |
| dc.contributor.author | Er, Özlem | |
| dc.contributor.author | Turna, Hande | |
| dc.contributor.author | Yanmaz, Teoman | |
| dc.contributor.author | Yıldız, Özcan | |
| dc.contributor.author | Mandel, Nil | |
| dc.contributor.author | Serdengeçti, Suheyla | |
| dc.contributor.buuauthor | Evrensel, Türkkan | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.orcid | 0000-0002-9732-5340 | |
| dc.contributor.researcherid | AAJ-1027-2021 | |
| dc.date.accessioned | 2024-01-11T08:05:01Z | |
| dc.date.available | 2024-01-11T08:05:01Z | |
| dc.date.issued | 2006 | |
| dc.description | Bu çalışma, 29 Eylül, 03 Ekim, 2006 tarihlerinde İstanbul[Türkiye]’de düzenlenen 31. Congress of the European-Society-for-Medical-Oncology Kongresi‘nde bildiri olarak sunulmuştur. | |
| dc.description.sponsorship | European Soc Med Oncol | |
| dc.identifier.citation | Özgüroğlu, M. vd. (2006). ''Phase II trial of a combination of weekly docetaxel and four-weekly carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC)''. Annals of Oncology, 17(Supplement 9), 225-225. | |
| dc.identifier.eissn | 1569-8041 | |
| dc.identifier.endpage | 225 | |
| dc.identifier.issn | 0923-7534 | |
| dc.identifier.issue | Supplement 9 | |
| dc.identifier.startpage | 225 | |
| dc.identifier.uri | https://hdl.handle.net/11452/38954 | |
| dc.identifier.volume | 17 | |
| dc.identifier.wos | 000248078900768 | |
| dc.indexed.scopus | Scopus | |
| dc.indexed.wos | SCIE | |
| dc.indexed.wos | CPCIS | |
| dc.language.iso | en | |
| dc.publisher | Elsevier | |
| dc.relation.collaboration | Yurt içi | |
| dc.relation.journal | Annals of Oncology | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Oncology | |
| dc.subject.wos | Oncology | |
| dc.title | Phase II trial of a combination of weekly docetaxel and four-weekly carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC) | |
| dc.type | Article | |
| dc.wos.quartile | Q1 (Oncology) | |
| dspace.entity.type | Publication | |
| local.contributor.department | Tıp Fakültesi | |
| local.indexed.at | PubMed |
Dosyalar
Lisanslı seri
1 - 1 / 1
